Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1805670 | 0.82 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10TSHRGAA | |
| SCHEMBL7931116 | 0.81 | ALDH1A1 (0.35) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL2409855 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TSHRGAA | |
| SCHEMBL29631686 | 0.79 | ALOX15 (0.54) | ALDH1A1LMNAHSD17B10TSHRGAA | |
| SCHEMBL960528 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TSHRGAA | |
| SCHEMBL19770548 | 0.79 | NAAA (0.39) | ALDH1A1LMNAHSD17B10TDP1GAA | |
| SCHEMBL1803406 | 0.79 | ALDH1A1 (0.59) | ALDH1A1LMNAHSD17B10TSHRTDP1 | |
| SCHEMBL80190 | 0.79 | THRB (0.50) | ALDH1A1LMNAHSD17B10TSHRTDP1 | |
| SCHEMBL3964618 | 0.77 | HCAR2 (0.48) | ALDH1A1LMNAHSD17B10RAB9A | |
| SCHEMBL66308 | 0.77 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-118983520-A | Preparation of lithium iron manganese phosphate battery electrolyte | 安徽得壹能源科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| EP-3986366-B1 | COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE, AT LEAST ONE NON-AMINO SILICONE AND WATER, THE ALKOXYSILANE/NON-AMINO SILICONE MASS RATIO RANGING FROM 95/5 TO 5/95 | OREAL (FR) | 2024-09-11 | — | — | EP | claimed |
| WO-2024172770-A1 | PRINTABLE WAX, METHOD OF PRINTING, AND METHOD FOR FLOW VISCOSITY CONTROL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-08-22 | — | — | WO | claimed |
| CN-117790906-A | Additive for lithium ion battery electrolyte and lithium iron manganese phosphate battery electrolyte | 昆明理工大学 | 2024-03-29 | — | — | CN | claimed |
| US-20240093058-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | MERCK PATENT GMBH (DE) | 2024-03-21 | — | — | US | claimed |
| CN-114007576-B | Anhydrous composition comprising at least one aminosilicone, at least one alkoxysilane and at least one colorant | 莱雅公司 | 2023-12-01 | — | — | CN | claimed |
| EP-4274866-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | Merck Patent GmbH (DE) | 2023-11-15 | — | — | EP | claimed |
| CN-115368982-A | Anti-reflective coating cleaning and post etch residue removal composition with metal, dielectric and nitride compatibility | 恩特格里斯公司 | 2022-11-22 | — | — | CN | claimed |
| US-20220331228-A1 | ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT | L'OREAL (FR) | 2022-10-20 | — | — | US | claimed |
| WO-2007040834-A2 | PLURAL TREATMENT STEP PROCESS FOR TREATING DIELECTRIC FILMS | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040856-A2 | PLASMA-ASSISTED VAPOR PHASE TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| US-20070077782-A1 | Treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077353-A1 | Plasma-assisted vapor phase treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077781-A1 | Plural treatment step process for treating dielectric films | TOKYO ELECTRON LIMTED (JP) | 2007-04-05 | — | — | US | claimed |
| WO-2006091264-A1 | METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM | TOKYO ELECTRON LIMITED (JP) | 2006-08-31 | — | — | WO | claimed |
| US-20050215072-A1 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2005-09-29 | — | — | US | claimed |
| US-20040166075-A1 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | L'OREAL S.A. | 2004-08-26 | — | — | US | claimed |
| US-20030012756-A9 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | HILTI AKTIENGESELLSCHAFT (LI) | 2003-01-16 | — | — | US | claimed |
| US-20020041856-A1 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | JEANNE-ROSE VALERIE (FR) | 2002-04-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040166075-A1 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | KRT18, VIM, CDH1 | ALDH1A1 4159/4885LMNA 451/4885HSD17B10 4022/4885 |
| US-20030012756-A9 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | KRT18, VIM, CDH1 | ALDH1A1 4159/4885LMNA 451/4885HSD17B10 4022/4885 |
| US-20220331228-A1 | ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT | KRT18, SHH, VIM | ALDH1A1 1160/4885LMNA 784/4885HSD17B10 2213/4885 |
| US-20020041856-A1 | Use of an organometallic compound to protect and/or strengthen a keratin material, and treatment process | KRT18, VIM, CDH1 | ALDH1A1 4159/4885LMNA 451/4885HSD17B10 4022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.